National HealthCare Corporation Financial Ratios — NHC Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	22.91	18.56	18.69	13.5	13.01	13.3	13.85	12.6	12.75	7.5	22.49	3.39	9.94	14.16	15.14
Return on Assets (%)	7.65	6.61	6.77	5.19	5.01	4.74	5.15	5.42	5.76	3.16	10.02	1.68	5.17	7.19	7.87
Return on Capital (%)	15.31	13.15	13.51	10.33	10.12	9.97	11.09	11.01	10.26	5.55	17.34	3.11	8.74	11.96	12.89
Return on Invested Capital (%)	8.52	6.6	7.01	5.75	5.47	5.1	5.38	5.82	4.42	3.96	5.38	2.03	4.21	6.11	8.21
Gross Margin (%)	44.56	43.9	42.51	41.46	41.24	40.66	40.65	40.56	40.5	37.87	34.11	36.13	37.6	37.52	39.31
EBITDA Margin (%)	13.99	12.94	13.49	12	11.79	11.21	10.55	10.47	9.49	9.34	9.96	6.44	8.72	10.16	11.42
Operating Margin (%)	10.25	9.03	9.87	8.05	7.69	6.98	6.12	6.2	5.24	5.05	5.93	2.67	5.03	6.93	8.46
Incremental Operating Margin (%)	33.45	86.63	32.82	-9.3	-1.27	-30.96	-13.6	10.78	-53.64	16.71	34.54	-49.36	42.71	20.74	17.49
Pretax Margin (%)	12.85	12.28	12.95	9.77	9.41	8.68	7.73	7.64	8.83	5.35	14.84	2.53	7.77	10.51	10.7
Profit Margin (%)	8.4	7.79	8.19	6.12	5.86	5.47	5.83	6.01	6.85	4.27	13.71	2.09	5.85	7.85	7.91
Net Income to Common Margin (%)	7.28	6.65	7.09	5.13	5.11	5.47	5.83	6.01	6.85	4.27	13.71	2.09	5.85	7.85	7.91
Effective Tax Rate (%)	34.61	36.56	36.76	37.36	37.68	36.99	25.31	21.61	22.77	19.9	7.3	26.64	26.43	25.16	24.52
Dvd Payout Ratio (%)	28.32	60.93	31.23	41.84	50.2	51.04	51.19	51.04	46.07	75.81	22.95	197.64	55.76	36.15	30.91
Sustainable Growth Rate (%)	16.42	7.25	12.86	7.85	6.48	6.51	6.76	6.17	6.88	1.81	17.33	-3.31	4.4	9.04	10.46

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	10	10	10	47	154	150	127	78	232	194	167	126	93	215	87
ST Debt	- -	- -	- -	3	3	3	4	4	38	30	32	34	30	39	41
LT Debt	10	10	10	44	150	147	123	74	194	164	134	92	63	175	46
Total Debt/EBITDA	0.09	0.1	0.09	0.45	1.44	1.45	1.25	0.76	2.45	2.12	1.66	1.82	0.94	1.63	0.5
Net Debt/EBITDA	-0.47	-0.58	-0.67	-0.57	0.77	0.9	0.4	0.11	-0.43	-1.61	-1.07	-0.85	-1.08	0.46	-0.3
Total Debt/EBIT	0.13	0.15	0.13	0.66	2.2	2.33	2.15	1.28	4.45	3.92	2.78	4.38	1.63	2.39	0.68
Net Debt/EBIT	-0.64	-0.83	-0.92	-0.85	1.17	1.45	0.69	0.19	-0.77	-2.97	-1.79	-2.04	-1.86	0.68	-0.41
EBITDA to Interest Expense	244.23	216.45	321.49	48.3	40.97	26.26	20.79	21.86	30.17	65.46	119.13	122.95	307.07	31.89	27.2
EBITDA-CapEx/Interest Expense	191.47	168.09	190.26	23.68	18.57	10.38	14.17	15.52	21.75	49.82	72.51	69.31	220.96	25.22	21.48
EBIT to Interest Expense	178.99	150.97	235.24	32.41	26.74	16.36	12.07	12.94	16.64	35.42	71	51.03	177.34	21.74	20.15
Interest Expense	- -	- -	- -	2	3	4	5	5	3	1	1	1	- -	4	6
Common Equity/Total Assets	30.48	30.29	32.34	32.03	35.22	36.06	38.26	47.79	43	41.35	47.69	51.5	52.47	49.35	54.58
Long-Term Debt/Equity (%)	1.63	1.52	1.45	5.93	23.81	21.92	17.49	10.09	24.85	20.56	14.79	10.47	6.94	17.84	4.28
Long-Term Debt/Capital (%)	2.24	2.17	2	7.75	28.8	27.06	22.5	12.44	24.64	21.59	15.97	11.69	8.07	18.08	4.96
Long-Term Debt/Total Assets (%)	1.15	1.08	1.02	4.05	14.37	13.49	11.22	6.86	15.05	12.05	9.58	7.2	4.82	11.51	3.01
Total Debt/Equity (%)	1.63	1.52	1.45	6.35	24.33	22.44	18.02	10.63	29.78	24.31	18.34	14.35	10.26	21.84	8.1
Total Debt/Capital (%)	2.24	2.17	2	8.3	29.43	27.7	23.17	13.1	29.53	25.52	19.81	16.02	11.93	22.14	9.4
Total Debt/Total Assets (%)	1.15	1.08	1.02	4.34	14.69	13.81	11.56	7.22	18.03	14.24	11.88	9.87	7.12	14.09	5.7
Net Debt to Equity	-8.34	-8.64	-10.42	-8.14	12.96	13.99	5.81	1.6	-5.18	-18.43	-11.84	-6.69	-11.76	6.19	-4.92
Net Debt/Capital (%)	-13.25	-14.39	-17.19	-12.16	16.92	18.15	8.38	2.13	-5.48	-23.99	-14.67	-8.07	-15.84	6.81	-6.34
EBITDA	108	98	106	105	107	104	102	103	95	92	101	69	99	132	173
EBITDA-CapEx	85	76	63	51	48	41	69	73	68	70	61	39	72	104	137
Operating Income (Loss)	79	69	78	70	70	64	59	61	52	50	60	29	57	90	128

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.66	0.76	1.11	1.1	1.02	1.09	1.28	1.16	1.04	1.15	0.97	0.92	1.04	0.92	1.01
Current Ratio	1.67	1.82	1.79	1.76	1.85	1.93	2.12	2.04	1.75	1.62	1.62	1.79	1.89	1.81	1.82
Quick Ratio	1.02	1.15	1.59	1.56	1.61	1.69	1.88	1.79	1.53	1.47	1.34	1.43	1.55	1.5	1.56
CFO/Avg Current Liab	0.37	0.29	0.52	0.47	0.5	0.6	0.62	0.63	0.57	0.85	0.23	0.04	0.54	0.48	0.76
Common Equity/Total Assets	30.48	30.29	32.34	32.03	35.22	36.06	38.26	47.79	43	41.35	47.69	51.5	52.47	49.35	54.58
Long-Term Debt/Equity (%)	1.63	1.52	1.45	5.93	23.81	21.92	17.49	10.09	24.85	20.56	14.79	10.47	6.94	17.84	4.28
Long-Term Debt/Capital (%)	2.24	2.17	2	7.75	28.8	27.06	22.5	12.44	24.64	21.59	15.97	11.69	8.07	18.08	4.96
Long-Term Debt/Total Assets (%)	1.15	1.08	1.02	4.05	14.37	13.49	11.22	6.86	15.05	12.05	9.58	7.2	4.82	11.51	3.01
Total Debt/Equity (%)	1.63	1.52	1.45	6.35	24.33	22.44	18.02	10.63	29.78	24.31	18.34	14.35	10.26	21.84	8.1
Total Debt/Capital (%)	2.24	2.17	2	8.3	29.43	27.7	23.17	13.1	29.53	25.52	19.81	16.02	11.93	22.14	9.4
Total Debt/Total Assets (%)	1.15	1.08	1.02	4.34	14.69	13.81	11.56	7.22	18.03	14.24	11.88	9.87	7.12	14.09	5.7
CFO/Total Liabilities	31.84	23.97	34.55	24.1	20.12	21.75	24.03	28.41	19.72	36.05	12.61	2.2	27.78	19.82	40.96
CFO/CapEx	3.52	2.93	2.36	1.54	1.43	1.45	2.92	3.31	3.79	9.29	1.58	0.29	3.99	3.89	5.08
Altman's Z-Score	3.2	3.23	3.22	3.19	3	3.38	3.22	4.05	3.23	2.68	3.17	3.45	4.34	3.99	5.33

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	10.43	10.24	10.06	10.99	11.13	11.09	11.39	10.65	10.47	10.74	10.88	10.96	10.95	10.64	11.07
Days Sales Outstanding	34.99	35.65	36.27	33.23	32.8	32.93	32.05	34.26	34.85	33.99	33.54	33.32	33.34	34.29	32.99
Inventory Turnover	56.14	60.65	65.7	71.5	72.51	72.7	78.04	79.7	79.52	75.12	76.72	87.58	98.43	98.74	109.43
Days Inventory Outstanding	6.5	6.02	5.56	5.11	5.03	5.02	4.68	4.58	4.59	4.86	4.76	4.17	3.71	3.7	3.34
Accounts Payable Turnover	41.21	41.8	38.47	35.28	29.62	28.3	33.07	32.63	30.67	30.52	30.54	34.71	39.42	36.37	38.12
Accounts Payable Turnover Days	8.86	8.73	9.49	10.35	12.32	12.9	11.04	11.19	11.9	11.96	11.95	10.51	9.26	10.04	9.58
Cash Conversion Cycle	32.64	32.94	32.34	27.98	25.51	25.05	25.7	27.65	27.53	26.89	26.35	26.97	27.79	27.95	26.75
Inventory to Cash Days	28.49	29.63	30.72	28.12	27.76	27.9	27.38	29.68	30.26	29.13	28.78	29.15	29.63	30.59	29.65
Inventories	7	7	7	7	8	8	7	7	7	9	9	7	7	9	8
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	7	7	7	7	8	8	7	7	7	9	9	7	7	9	8

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	577	651	746	868	857	1,147	926	1,194	1,320	1,016	1,043	917	1,415	1,656	2,121
- Cash & Cash Equivalents	61	67	82	70	38	26	59	43	50	147	108	59	107	76	93
+ Preferred Equity and Hybrid Capital	171	171	171	170	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	1	1	- -	3	5	3	2	3	6
+ Total Debt	10	10	10	47	154	150	127	78	232	194	167	126	93	215	87
Enterprise Value	612	658	739	883	856	1,133	855	1,090	1,350	890	959	863	1,286	1,657	1,958
Total Capital	446	461	499	561	522	542	547	596	786	760	841	786	783	970	926
Total Debt/Capital (%)	2.24	2.17	2	8.3	29.43	27.7	23.17	13.1	29.53	25.52	19.81	16.02	11.93	22.14	9.4
Total Debt / EV	0.02	0.02	0.01	0.05	0.18	0.13	0.15	0.07	0.17	0.22	0.17	0.15	0.07	0.13	0.04
EV/Sales	0.79	0.86	0.94	1.01	0.94	1.23	0.89	1.11	1.35	0.91	0.95	0.8	1.13	1.28	1.29
EV/EBITDA	5.65	6.68	6.95	8.44	8.01	10.95	8.41	10.62	14.27	9.72	9.52	12.47	12.93	12.57	11.3
EV/EBIT	7.71	9.58	9.5	12.58	12.28	17.57	14.49	17.94	25.87	17.96	15.98	30.05	22.39	18.44	15.26
EV/Cash Flow to Firm	7.4	10.17	7.21	10.6	10.07	12.13	8.71	10.68	13.16	4.36	15.18	94.32	11.54	15.01	10.31
EV/Free Cash Flow to Firm	5.77	7.59	5.06	6.46	5.97	7.26	6.55	8.27	10.47	3.93	9.35	21.94	9.23	12.01	8.65
Diluted Market Cap	688	780	900	894	894	1,153	927	1,195	1,328	1,021	1,047	919	1,421	1,678	2,145
Diluted Enterprise Value	807	894	999	1,041	1,009	1,276	996	1,231	1,510	1,071	1,112	990	1,409	1,819	2,145
EV per Share	44.4	47.49	53.46	63.91	61.64	74.86	56.28	71.6	88.38	58.16	62.47	56.03	84.03	107.66	126.56
TTM Sales	773	761	789	872	907	924	964	980	996	981	1,011	1,074	1,142	1,298	1,518
TTM EBITDA	108	98	106	105	107	104	102	103	95	92	101	69	99	132	173
TTM Operating Income	79	69	78	70	70	64	59	61	52	50	60	29	57	90	128
TTM Cash Flow to Firm	83	65	103	83	85	93	98	102	103	204	63	9	111	110	190
TTM Free Cash Flow to Firm	106	87	146	137	143	156	130	132	129	226	103	39	139	138	226

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	6.5	9.04	6.18	6.61	6.31	7.51	7.31	9.32	10.49	4.53	10.29	23.6	10.22	12.44	9.68
EV/EBIT	7.71	9.58	9.5	12.58	12.28	17.57	14.49	17.94	25.87	17.96	15.98	30.05	22.39	18.44	15.26
Enterprise Value	612	658	739	883	856	1,133	855	1,090	1,350	890	959	863	1,286	1,657	1,958
Low Price	29.97	40.55	44.68	49.06	58.98	57.16	57.73	57	70.89	55.88	62.57	57.61	51.56	87.03	89.14
EV/Sales	0.79	0.86	0.94	1.01	0.94	1.23	0.89	1.11	1.35	0.91	0.95	0.8	1.13	1.28	1.29
EV/EBITDA	5.65	6.68	6.95	8.44	8.01	10.95	8.41	10.62	14.27	9.72	9.52	12.47	12.93	12.57	11.3
Price/Earnings	10.25	12.87	13.33	19.42	18.5	22.7	16.47	20.26	19.35	24.28	7.52	40.85	21.18	16.24	17.67
Price/Earnings Average	10.45	12.45	11.95	17.28	19.07	19.47	18.48	18	18.08	25.07	7.9	45.89	14.76	16.63	14.02
Price/Earnings High	12.98	13.59	14.01	19.99	20.81	23.65	20.81	21.92	20.05	32.3	8.83	51.73	22.5	20.92	18.63
Price/Earnings Low	7.33	11.09	11.05	15.16	17.68	17.12	15.6	14.72	15.87	20.43	6.93	39.55	11.82	13.14	11.49
Price/Book Value	2.18	2.33	2.34	2.52	2.33	2.93	2.21	2.31	2.39	1.8	1.56	1.4	2.06	2.2	2.55
Price/Book Value Average	2.22	2.25	2.1	2.24	2.4	2.51	2.48	2.05	2.23	1.86	1.64	1.57	1.43	2.25	2.02
Price/Book Value High	2.76	2.46	2.46	2.6	2.62	3.05	2.79	2.5	2.47	2.4	1.83	1.77	2.19	2.83	2.68
Price/Book Value Low	1.56	2.01	1.94	1.97	2.23	2.21	2.09	1.68	1.96	1.52	1.43	1.35	1.15	1.78	1.66
Price/Tangible Book Value	1.37	1.39	1.49	1.59	1.4	1.76	1.35	1.67	1.74	1.31	1.42	1.31	1.92	2.09	2.4
Price/Tangible Book Value Average	1.4	1.35	1.34	1.41	1.44	1.51	1.51	1.49	1.63	1.35	1.49	1.47	1.34	2.14	1.9
Price/Tangible Book Value High	1.74	1.47	1.57	1.64	1.57	1.83	1.71	1.81	1.8	1.74	1.67	1.65	2.04	2.69	2.53
Price/Tangible Book Value Low	0.98	1.2	1.24	1.24	1.34	1.33	1.28	1.22	1.43	1.1	1.31	1.26	1.07	1.69	1.56
Price/Sales	0.75	0.86	0.94	1	0.95	1.24	0.96	1.22	1.32	1.04	1.03	0.85	1.24	1.28	1.4
Price/Sales Average	0.76	0.83	0.85	0.89	0.97	1.07	1.08	1.08	1.24	1.07	1.08	0.96	0.86	1.31	1.11
Price/Sales High	0.95	0.9	0.99	1.02	1.06	1.29	1.21	1.32	1.37	1.38	1.21	1.08	1.32	1.64	1.47
Price/Sales Low	0.53	0.74	0.78	0.78	0.9	0.94	0.91	0.89	1.09	0.87	0.95	0.83	0.69	1.03	0.91
Price/Cash Flow	7.01	10.12	7.28	10.6	10.28	12.62	9.8	12.13	13.18	5	16.71	104.89	12.72	15.43	11.46
Price/Cash Flow Average	7.14	9.79	6.53	9.43	10.6	10.83	11	10.78	12.32	5.16	17.55	117.83	8.87	15.8	9.09
Price/Cash Flow High	8.88	10.69	7.66	10.9	11.56	13.15	12.38	13.13	13.66	6.65	19.61	132.83	13.51	19.87	12.08
Price/Cash Flow Low	5.01	8.73	6.04	8.27	9.83	9.52	9.28	8.82	10.81	4.21	15.39	101.55	7.1	12.49	7.45
Price/Free Cash Flow Average	6.63	8.74	5.54	5.88	6.5	6.44	8.21	8.28	9.8	4.68	10.81	26.51	7.12	12.73	7.68
Price/Free Cash Flow High	8.24	9.55	6.49	6.8	7.09	7.83	9.24	10.09	10.87	6.03	12.08	29.89	10.85	16.01	10.21
Price/Free Cash Flow Low	4.65	7.79	5.12	5.16	6.03	5.66	6.93	6.77	8.61	3.81	9.48	22.85	5.7	10.06	6.3
EV/Sales Average	0.92	0.98	0.97	1.06	1.1	1.2	1.15	1.12	1.42	1.12	1.15	1.02	0.85	1.42	1.11
EV/Sales High	1.1	1.05	1.12	1.19	1.19	1.43	1.28	1.36	1.56	1.43	1.27	1.15	1.31	1.75	1.47
EV/Sales Low	0.69	0.89	0.91	0.95	1.03	1.07	0.98	0.92	1.27	0.92	1.01	0.89	0.68	1.14	0.91
EV/EBITDA Average	6.54	7.55	7.21	8.8	9.35	10.7	10.89	10.69	14.96	12.01	11.52	15.9	9.79	13.93	9.71
EV/EBITDA High	7.86	8.14	8.3	9.95	10.1	12.75	12.18	12.94	16.38	15.31	12.8	17.79	14.99	17.24	12.91
EV/EBITDA Low	4.92	6.86	6.74	7.89	8.75	9.55	9.3	8.8	13.37	9.89	10.18	13.84	7.81	11.23	7.96
EV/EBIT Average	8.93	10.83	9.85	13.11	14.32	17.18	18.77	18.05	27.13	22.19	19.33	38.31	16.96	20.43	13.11
EV/EBIT High	10.73	11.68	11.34	14.83	15.48	20.46	20.98	21.86	29.7	28.3	21.47	42.87	25.95	25.29	17.42
EV/EBIT Low	6.71	9.83	9.2	11.76	13.4	15.34	16.02	14.87	24.24	18.27	17.08	33.35	13.53	16.48	10.75
Last Price	41.9	47.02	53.91	62.84	61.7	75.79	60.94	78.45	86.43	66.41	67.94	59.5	92.42	107.56	137.09
High Price	53.08	49.68	56.69	64.66	69.4	78.99	77.01	84.9	89.55	88.35	79.73	75.35	98.17	138.49	144.53
Enterprise Value Average	708	744	767	920	999	1,108	1,107	1,097	1,415	1,100	1,159	1,101	974	1,837	1,682
Enterprise Value High	851	802	883	1,041	1,079	1,319	1,238	1,329	1,550	1,402	1,288	1,232	1,491	2,274	2,236
Enterprise Value Low	532	676	717	825	934	989	945	904	1,265	905	1,025	958	777	1,481	1,379

Shares Outstanding	14	14	14	14	15	15	15	15	15	15	15	15	15	15	16
Diluted Weighted Avg Shares	16	17	17	14	14	15	15	15	15	15	15	15	15	16	16
Basic Weighted Avg Shares	14	14	14	14	14	15	15	15	15	15	15	15	15	15	15
Revenue per Share	56.14	54.94	57.05	63.09	65.28	61.02	63.46	64.39	65.25	64.07	65.87	69.71	74.56	84.32	98.1
EBITDA per Share	7.85	7.11	7.69	7.57	7.69	6.84	6.69	6.74	6.19	5.98	6.56	4.49	6.5	8.57	11.2
Operating Income per Share	5.76	4.96	5.63	5.08	5.02	4.26	3.88	3.99	3.42	3.24	3.91	1.86	3.75	5.84	8.3
Basic EPS, GAAP	4.09	3.65	4.05	3.24	3.34	3.34	3.7	3.87	4.47	2.74	9.03	1.46	4.36	6.62	7.76
Basic EPS from Cont Ops	4.72	4.28	4.67	3.86	3.83	3.34	3.67	3.86	4.45	2.74	9.06	1.3	4.26	6.63	7.92
Diluted EPS, GAAP	3.43	3.05	3.35	3.14	3.2	3.32	3.69	3.87	4.44	2.72	8.99	1.45	4.34	6.53	7.67
Diluted EPS from Cont Ops	3.96	3.57	3.87	3.75	3.67	3.32	3.66	3.85	4.43	2.73	9.02	1.29	4.25	6.54	7.84
Dividend per Share	1.79	2.85	1.89	1.98	2.17	1.7	1.86	1.96	2.04	2.09	2.09	2.25	2.32	2.4	2.5
Cash Flow per Share	5.98	4.65	7.4	5.93	6	6	6.22	6.47	6.56	13.28	4.07	0.57	7.26	6.97	11.96
Free Cash Flow per Basic Share	4.28	3.06	4.26	2.07	1.8	1.87	4.09	4.51	4.83	11.85	1.5	-1.39	5.44	5.18	9.61
Cash & Equivalents per Share	10.6	12.56	13.5	14.64	11.11	10.86	13.05	12.05	13.28	21.13	16.68	11.85	14.61	14.04	16.53
Book Value per Share	19.26	20.22	23.02	24.9	26.51	25.91	27.62	33.93	36.23	36.79	43.61	42.62	44.92	48.87	53.85
Tangible Book Value per Share	30.56	33.79	36.15	39.52	44.16	43.08	45.15	46.86	49.64	50.76	47.77	45.57	48.02	51.5	57.15

National HealthCare Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)